The GreenMark Team

Steven Bloembergen, Ph.D.

Steven-BloembergenSteven Bloembergen, Ph.D.
Founder, Chairman and CEO

Dr. Steven Bloembergen founded GreenMark Biomedical in Michigan in 2016, with a vision to deliver health based benefits to society through biobased targeting technologies. GreenMark’s mission is to “Enable dentists to preserve teeth through early diagnosis and treatment”. Steven has 30 years of leadership experience in the development and commercialization of biomaterials. He started a company called EcoSynthetix (ECO) in Lansing, Michigan in 1996, now a global corporation. In January 2011 ECO opened its state-of-the-art Center of Innovation facility in Burlington, Ontario where it pursues the development of biobased products for industrial applications. He and his team helped prove out the technology with pilot lines and production sites in the US and Europe, building a manufacturing capacity for starch nanoparticles in excess of 200 million lbs/yr. The company held its IPO in August 2011 (TSX: ECO) and was Canada’s largest IPO in the Cleantech sector. In 2012, Steven received the Ernst and Young “2012 Entrepreneur of the Year Award”. He developed a broad global IP portfolio and established a network of university collaborators. These collaborations using ECO’s starch nanoparticles for dental and medical applications resulted in the foundational technology for GreenMark. Steven is the inventor of over 25 patent families related to biomaterials. He received his Ph.D. in Polymer Science and Engineering from the University of Waterloo, Ontario.

Wendy Bloembergen, MD, MS

Wendy-BloembergenWendy Bloembergen, MD, MS
Vice President Clinical Affairs

Dr. Wendy Bloembergen is an Internist and Nephrologist who is pursuing her entrepreneurial interests after spending a number of years raising her family.  Prior to this Wendy consulted for a venture capital firm as a medical analyst.  Before this taste of the business world, she maintained an academic position at the University of Michigan, Department of Internal Medicine (Nephrology), where she treated patients and served as a Principal and Co-Investigator on multiple NIH grants focused on epidemiologic studies of patients with chronic renal disease.  She is the author of more than 20 peer reviewed articles and several book chapters.  Wendy received her MD from the University of Western Ontario, London, Ontario, and her Internal Medicine and Nephrology fellowships at McMaster University, Hamilton, Ontario and University of Western Ontario.  She subsequently completed a Research Fellowship at the University of Michigan Medical School and an MS in Clinical Research Design and Statistical Analysis at the University of Michigan School of Public Health.

Nathan Jones, M.Sc., Ph.D.

Nathan Jones, M.Sc., Ph.D.
Vice President Technology

Dr. Nathan Jones holds an Honors Nanotechnology Engineering, Co-op degree from the University of Waterloo (UW) and Waterloo Institute of Nanotechnology (WIN).  He has a Master’s and Ph.D. degree in Macromolecular Science and Engineering from the University of Michigan (UM), completing his degree requirements in September 2017.  His thesis, entitled “Harnessing Functionalized Polysaccharides for Medical and Dental Applications”, focused in part on targeted anti-cancer drug delivery applications involving starch nanoparticles.  Nathan and his thesis advisor Prof. Joerg Lahann collaborated closely with Prof. Brian Clarkson, Department of Cariology, Restorative Sciences and Endodontics, at the UM School of Dentistry.  They are co-inventors of GreenMark’s targeted dental technology based on starch nanoparticles.  In October 2017, Nathan managed a 6 month GreenMark-State of Michigan funded Small Company Innovation Program (SCIP) project with Prof. Carlos González Cabezas, an expert in dental diagnostics and remineralization at the UM School of Dentistry.  The collaboration with Prof. González continues as part of a 6 month Phase 2 SCIP project.  Nathan has been collaborating with Steven Bloembergen since 2009, first at EcoSynthetix, then at UW and at UM.  He has been actively involved in the company’s startup activities, strategic planning and execution.  Nathan joined GreenMark full time in May 2018.

Adam G. Laird, J.D.

Adam G. Laird, J.D.
Director of Business Development

Mr. Adam Laird graduated from the University of Michigan Law School in December 2018. While there, he focused on entrepreneurial and venture capital legal issues. Adam provided pro-bono legal services through Michigan Law’s Entrepreneurship clinic and Community and Economic Development clinic. He has prior experience working within venture capital firms and startups. He was a summer associate on Invest Detroit Ventures’ venture capital team, where he led the due diligence process on GreenMark. Prior to attending law school, he worked as the events manager for Spotluck – a Bethesda, Maryland based startup. Adam was a part of the team that represented the Ross School of Business in the 2018 Venture Capital Investment Competition, where they were regional finalists. He joined GreenMark in January 2019.

Joerg Lahann, Ph.D.

Joerg-LahannJoerg Lahann, Ph.D.
Director and Advisor

Dr. Joerg Lahann is a Professor of Chemical Engineering, Materials Science and Engineering and Biomedical Engineering at the University of Michigan (UM).  He also serves as the Director of the UM Biointerfaces Institute and as the co-Director of the Institute for Functional Interfaces at the Karlrsruhe Institute of Technology, Germany.  Joerg is a co-inventor of GreenMark’s dental technology.  He is a co-author of more than 190 papers and has contributed to more than 30 patents and patent applications.  He has been selected by Technology Review as one of the top 100 young scientists and is the recipient of the 2007 Nanoscale Science and Engineering Award, an NSF-CAREER award, and both a single-PI and a team Idea award (2006 & 2011) from the US Department of Defense.  He serves on the board of Seventh Sense, a health technology company.  Joerg received a Ph.D. from the RWTH Aachen in Germany and completed postdoctoral training in the research group of Prof. Robert S. Langer at the Massachusetts Institute of Technology.  He joined the University of Michigan in 2003.

Kenneth J. Pienta, MD

Kenneth-PientaKenneth J. Pienta, MD
Director and Advisor

Dr. Kenneth J. Pienta is the Donald S. Coffey Professor of Urology and Director of Research at the Brady Urological Institute of the Johns Hopkins University School of Medicine.  He is also a Professor in the Departments of Oncology and Pharmacology and Molecular Sciences and serves as a faculty member in the Cellular and Molecular Medicine and Pathobiology Programs at the Johns Hopkins School of Medicine.  He is also a Professor of Chemical and Biomolecular Engineering in the Whiting School of Engineering at Johns Hopkins University.  Ken is a two-time American Cancer Society Clinical Research Professor Award recipient.  Ken has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development, and clinical application.  He has international expertise in the development of novel therapeutic programs for prostate cancer.  He is the author of more than 400 peer-reviewed articles, and been the principal investigator on numerous local and national clinical trials.  Ken is the holder of multiple patents, is co-founder of OncoFusion where he serves on the Scientific Advisory Board and he has served as a Scientifc Advisory Board member or consultant to biotechnology companies including Curis, Amgen, J&J, Millenium, Gtx, Myriad Genetic Labs and Compendia.

Frank van Luttikhuizen, CPA

Frank-van-LuttikhuizenFrank van Luttikhuizen, CPA
Director and Advisor

Frank van Luttikhuizen is a Chartered Professional Accountant.  Frank was CFO of EcoSynthetix Inc. from its inception in 1996 until he retired in 2009.  Prior to that he was a CFO for a venture company which made numerous investments in software ventures and a biotechnology venture in 1996.  He possesses strong intuitive and analytical skills and has experience in leading negotiations with customers, regulators, and stakeholder groups.  He was a board member for various private and public companies.  He has successfully managed organizations through significant strategic change through the development of key operating plans and by providing “hands-on” management, direction, coaching, and mentoring as required.  He has a Bachelor of Science degree from The University of Western Ontario and an Honors Bachelor of Commerce from the University of Windsor.

Mike Snyder, PE, CSP, CFPS

Mike Snyder, PE, CSP, CFPS
Director and Advisor

Mr. Michael (Mike) Snyder is a member of the BlueWater Angels Investment Network (see http://bluewaterangels.com/), and serves as their representative on the GreenMark Board. Mike is the Executive Vice President for DEKRA Process Safety (Americas), a Trusted Advisor in Chemical Process Safety Science. He previously served in a number of Supply Chain and EHS related roles for Dow Corning Corporation in a career spanning over 31 years.

Mike obtained a BS degree in Chemical Engineering from Cornell University and a MS in Occupational Safety and Health from Columbia Southern University. He is a Registered Professional Engineer, and currently serves as an Advisory Board Member for the Center for Chemical Process Safety (CCPS) and as a member of the National Fire Protection Association (NFPA) Standards Council. He also serves on several regional non-profit boards.